THIRD LEASE MODIFICATION AGREEMENTThird Lease Modification Agreement • May 5th, 2021 • Zymeworks Inc. • Pharmaceutical preparations
IN CONSIDERATION of the mutual covenants and agreements and other provisions herein contained and for other good and valuable consideration (the receipt and sufficiency of which is acknowledged), the parties agree as follows:
FIRST AMENDMENT TO COLLABORATION AGREEMENTCollaboration Agreement • May 5th, 2021 • Zymeworks Inc. • Pharmaceutical preparations • New York
This First Amendment (the “Amendment”) to the Agreement (as defined below), is entered into as of March 29, 2021 (the “Amendment Effective Date”), by and between Zymeworks Inc., a corporation organized and existing under the laws of British Columbia (“Zymeworks”), having a place of business at 540-1385 West 8th Avenue, Vancouver, BC, Canada V6H 3V9, and Beigene, Ltd., a Cayman Island exempted company incorporated with limited liability (“BeiGene”), having a place of business at c/o Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, Camana Bay, PO Box 1348, Grand Cayman KY1-1108, Cayman Islands. Zymeworks and BeiGene are each referred to individually as a “Party” and together as the “Parties”.
EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2021 • Zymeworks Inc. • Pharmaceutical preparations • Washington
ZYMEWORKS BIOPHARMACEUTICALS INC., a corporation registered in the State of Washington and having its principal place of business at 2100-1215 Fourth Avenue, Seattle, WA, 98161, USA
